560 followers
MA: Efficacy and response rates were similar between paliperidone palmitate and risperidone-LAIAs treatments for SCZ (A - PANSS-SMD and B - RR, respectively). PP showed increased risks of discontinuation for any reason (C) but not for AEs (D) https://t.co/